Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-400
Closed -$34.9K 1352
2025
Q2
$34.9K Sell
400
-17,000
-98% -$1.33M ﹤0.01% 1135
2025
Q1
$1.19M Buy
17,400
+6,400
+58% +$522K 0.05% 432
2024
Q4
$855K Buy
11,000
+1,800
+20% +$133K 0.03% 506
2024
Q3
$617K Sell
9,200
-19,100
-67% -$1.57M 0.02% 597
2024
Q2
$3.21M Buy
28,300
+26,700
+1,669% +$3.38M 0.11% 237
2024
Q1
$222K Buy
+1,600
New +$201K 0.01% 936

Other funds holding DXCM

Point72 (DIFC)'s DXCM Position: Q3 2025 in Review

Point72 (DIFC) increased its DexCom (DXCM) stake by 89% in Q3 2025, buying an estimated $11.7M and bringing the position to 312,430 shares worth $21M. The position accounts for 1.38% of the portfolio, ranked #14.

Point72 (DIFC) first reported a position in DXCM in Q1 2025 and has held it in 3 quarters since. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Point72 (DIFC) held 312,430 shares of DexCom worth $21M as of Q3 2025.
  • Point72 (DIFC) bought 147,230 DexCom shares in Q3 2025, an estimated $11.7M.
  • DexCom made up 1.38% of Point72 (DIFC)'s portfolio in Q3 2025, its #14 holding.
  • Point72 (DIFC) first reported a position in DexCom in Q1 2025 and has held it in 3 quarters since.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.